Education
About Us
Working with TipRanks
Follow Us
Sanuwave Health (SNWV)
NASDAQ:SNWV
Total Valuation
Sanuwave Health has a market cap or net worth of $323.70M. The enterprise value is $320.72M.
Market Cap$323.70M
Enterprise Value$320.72M
Share Statistics
Sanuwave Health has 8,568,005 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,568,005
Owned by Insiders17.78%
Owned by Institutions24.15%
Financial Efficiency
Sanuwave Health’s return on equity (ROE) is 2.47 and return on invested capital (ROIC) is 41.45%.
Return on Equity (ROE)2.47
Return on Assets (ROA)-1.04
Return on Invested Capital (ROIC)41.45%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee709.43K
Profits Per Employee-277.13K
Employee Count46
Asset Turnover1.08
Inventory Turnover1.95
Valuation Ratios
The current PE Ratio of Sanuwave Health is ―. Sanuwave Health’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value-8.07
Price to FCF―
Price to Operating Cash Flow227.78
PEG Ratio―
Income Statement
In the last 12 months, Sanuwave Health had revenue of 32.63M and earned -31.37M in profits. Earnings per share was -7.03.
Revenue32.63M
Gross Profit24.55M
Operating Income5.42M
Pretax Income-31.34M
Net Income-31.37M
EBITDA-16.56M
Earnings Per Share (EPS)-7.03
Cash Flow
In the last 12 months, operating cash flow was 1.50M and capital expenditures -1.60M, giving a free cash flow of -106.00K billion.
Operating Cash Flow1.50M
Free Cash Flow-106.00K
Free Cash Flow per Share-0.01
Dividends & Yields
Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change543.50%
50-Day Moving Average34.59
200-Day Moving Average28.66
Relative Strength Index (RSI)54.22
Average Volume (3m)53.31K
Important Dates
Sanuwave Health upcoming earnings date is Nov 7, 2025, TBA (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateNov 7, 2025
Ex-Dividend Date―
Financial Position
Sanuwave Health as a current ratio of 0.43, with Debt / Equity ratio of -8.00%
Current Ratio0.43
Quick Ratio0.34
Debt to Market Cap0.25
Net Debt to EBITDA-0.92
Interest Coverage Ratio0.40
Taxes
In the past 12 months, Sanuwave Health has paid 27.00K in taxes.
Income Tax27.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Sanuwave Health EV to EBITDA ratio is -7.12, with an EV/FCF ratio of 60.00.
EV to Sales3.61
EV to EBITDA-7.12
EV to Free Cash Flow60.00
EV to Operating Cash Flow48.03
Balance Sheet
Sanuwave Health has $8.50M in cash and marketable securities with $1.18M in debt, giving a net cash position of -$7.31M billion.
Cash & Marketable Securities$8.50M
Total Debt$1.18M
Net Cash-$7.31M
Net Cash Per Share-$0.85
Tangible Book Value Per Share-$5.31
Margins
Gross margin is 77.69%, with operating margin of 16.60%, and net profit margin of -96.13%.
Gross Margin77.69%
Operating Margin16.60%
Pretax Margin-96.05%
Net Profit Margin-96.13%
EBITDA Margin-50.75%
EBIT Margin-54.26%
Analyst Forecast
The average price target for Sanuwave Health is $47.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$47.50
Price Target Upside23.03% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast57.43%
EPS Growth Forecast-155.29%